M E Davies

1.3k total citations
15 papers, 1.1k citations indexed

About

M E Davies is a scholar working on Molecular Biology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M E Davies has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M E Davies's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Herpesvirus Infections and Treatments (4 papers) and RNA and protein synthesis mechanisms (4 papers). M E Davies is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Herpesvirus Infections and Treatments (4 papers) and RNA and protein synthesis mechanisms (4 papers). M E Davies collaborates with scholars based in United States, United Kingdom and Italy. M E Davies's co-authors include Anjalie Field, Helen C. Perry, Richard L. Tolman, Richard Liou, Corrille M. DeWitt, Wallace T. Ashton, Jon H. Condra, Richard J. Colonno, Joanne E. Tomassini and John I. Germershausen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

M E Davies

15 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M E Davies United States 11 580 429 225 182 159 15 1.1k
N. B. Finter United Kingdom 19 371 0.6× 218 0.5× 171 0.8× 87 0.5× 117 0.7× 46 1.1k
Fumio Kitame Japan 25 907 1.6× 495 1.2× 155 0.7× 86 0.5× 86 0.5× 53 1.3k
M. A. Brothers United States 9 332 0.6× 327 0.8× 259 1.2× 378 2.1× 48 0.3× 12 1.0k
P L Callahan United States 9 332 0.6× 662 1.5× 496 2.2× 423 2.3× 129 0.8× 9 1.3k
Marc P. Windisch South Korea 21 574 1.0× 502 1.2× 410 1.8× 77 0.4× 85 0.5× 57 1.6k
Annie Cahour France 19 402 0.7× 276 0.6× 332 1.5× 112 0.6× 33 0.2× 44 1.2k
B. Öberg Sweden 23 644 1.1× 495 1.2× 624 2.8× 74 0.4× 224 1.4× 67 1.6k
James W. Meador United States 16 274 0.5× 622 1.4× 435 1.9× 563 3.1× 100 0.6× 31 1.4k
M. M. Nemes United States 16 239 0.4× 305 0.7× 153 0.7× 97 0.5× 76 0.5× 20 917
Kenneth Simmen Belgium 20 892 1.5× 450 1.0× 459 2.0× 32 0.2× 87 0.5× 39 1.6k

Countries citing papers authored by M E Davies

Since Specialization
Citations

This map shows the geographic impact of M E Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M E Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M E Davies more than expected).

Fields of papers citing papers by M E Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M E Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M E Davies. The network helps show where M E Davies may publish in the future.

Co-authorship network of co-authors of M E Davies

This figure shows the co-authorship network connecting the top 25 collaborators of M E Davies. A scholar is included among the top collaborators of M E Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M E Davies. M E Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Capone, Stefania, Annalisa Meola, Bruno Bruni Ercole, et al.. (2006). A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques. Journal of Virology. 80(4). 1688–1699. 70 indexed citations
2.
Mee, A.P., et al.. (1996). Novel and sensitive detection systems for the vitamin D receptor — in situ-reverse transcriptase-polymerase chain reaction and immunogold cytochemistry. Journal of Molecular Endocrinology. 16(2). 183–195. 19 indexed citations
3.
Tomassini, Joanne E., M E Davies, J C Hastings, et al.. (1996). A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrobial Agents and Chemotherapy. 40(5). 1189–1193. 116 indexed citations
4.
Tomassini, Joanne E., Harold G. Selnick, M E Davies, et al.. (1994). Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrobial Agents and Chemotherapy. 38(12). 2827–2837. 166 indexed citations
5.
Condra, Jon H., Vinod Sardana, Joanne E. Tomassini, et al.. (1990). Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cells.. Journal of Biological Chemistry. 265(4). 2292–2295. 43 indexed citations
6.
Broni, B, Ilkka Julkunen, Jon H. Condra, et al.. (1990). Parental influenza virion nucleocapsids are efficiently transported into the nuclei of murine cells expressing the nuclear interferon-induced Mx protein. Journal of Virology. 64(12). 6335–6340. 21 indexed citations
7.
Colonno, Richard J., Jon H. Condra, Satoshi Mizutani, et al.. (1988). Evidence for the direct involvement of the rhinovirus canyon in receptor binding.. Proceedings of the National Academy of Sciences. 85(15). 5449–5453. 180 indexed citations
8.
Field, Anjalie, M E Davies, Helen C. Perry, et al.. (1986). Efficacy of 2′-nor-cyclicGMP in treatment of experimental herpes virus infections. Antiviral Research. 6(6). 329–341. 11 indexed citations
9.
Ashton, Wallace T., G.F. Reynolds, Richard L. Tolman, et al.. (1985). Synthesis and antiherpetic activity of (S)-, (R)-, and (.+-.)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosine. Journal of Medicinal Chemistry. 28(7). 926–933. 68 indexed citations
10.
Davies, M E, et al.. (1984). Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice. Antimicrobial Agents and Chemotherapy. 25(2). 238–241. 7 indexed citations
11.
Krown, Susan E., et al.. (1983). Phase I Trial with the Interferon Inducer Poly I:C/Poly-L-Lysine (Poly ICL). Journal of Interferon Research. 3(3). 281–290. 10 indexed citations
12.
Field, Anjalie, M E Davies, Corrille M. DeWitt, et al.. (1983). 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.. Proceedings of the National Academy of Sciences. 80(13). 4139–4143. 324 indexed citations
13.
Field, Anjalie, M E Davies, & A. A. Tytell. (1980). Determination of Antibodies to Double-Stranded RNA by Enzyme-Linked Immunosorbent Assay (ELISA). Experimental Biology and Medicine. 164(4). 524–529. 5 indexed citations
14.
Davies, M E & E Sabbadini. (1978). Inhibition of cell-mediated cytotoxicity by plastic-adherent cells in the spleens of mice treated with bcg and reacting to an allo- geneic tumor. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1353. 1 indexed citations
15.
Davies, M E. (1954). A Study of the Diffusible Lipase produced by Staphylococci and of its Immunological Activity. Journal of General Microbiology. 11(1). 37–44. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026